Inversion Therapeutics, Inc. research brief
CIK 2077706
Generated Nov. 19, 2026, 12:01 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: BURLINGAME California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 27, 2025 · D · 0001231919-25-000167 · Source evidence
Reported offering amount: 11110779 USD. Reported amount sold: 6910684 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Inversion Therapeutics, Inc. research brief,” CIK 2077706, retrieved Nov. 19, 2026, 12:01 a.m.. Cite the specific accessions used. No amounts have been summed.